TOT Biopharm
2010
FOUNDED
PUBLIC
STATUS
301-400
EMPLOYEES
01875
STOCK SYMBOL
$0.49
SHARE PRICE
(As of Friday Closing)
Description
TOT Biopharm International Co Ltd p is engaged in the research, development and licensing of self-developed biological drug.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
HKG
Primary Office
- 120 Changyang Street
- Suzhou Industrial Park
- Suzhou, 215024
- China
+86 0512 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore TOT Biopharm’s full profile, request a free trial.
TOT Biopharm Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.48 - $0.82 | $278M | $0.49 | -$0.07 | 270K | 570M |
TOT Biopharm Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2018
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
|---|---|---|---|
| Revenue | 5,929 | 5,929 | 7,637 |
| EBITDA | (37,932) | (37,932) | (20,034) |
| Net Income | (40,552) | (40,552) | (22,002) |
| Total Assets | 98,450 | 98,450 | 55,763 |
| Total Debt | 2,272 | 2,272 | 41,170 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
TOT Biopharm Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore TOT Biopharm‘s full profile, request access.
Request full access to PitchBookTOT Biopharm Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore TOT Biopharm‘s full profile, request access.
Request full access to PitchBookTOT Biopharm Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Rongjin Lin | TOT Biopharm | Chairman | 000 0000 |